Literature DB >> 11229870

Mouse models of hyperlipidemia and atherosclerosis.

S Fazio1, M F Linton.   

Abstract

The mouse is the most utilized model to study lipids and atherosclerosis. Before the advent of the techniques of genetic manipulation it was well known that different inbred strains had varying degrees of susceptibility to diet-induced atherosclerosis. The C57BL/6 mouse was adopted as the standard even though the arterial lesions induced by even extreme diets were limited in size, complexity, and distribution. This changed with the production of several gene knockout and transgenic mice, which in many cases produced remarkable effects on plasma lipoproteins and arterial lesions even without dietary manipulations. The most typical example remains the apoE deficient model, in which a massive hyperlipidemia is accompanied with the development of severe atherosclerotic plaques at the aortic root and throughout the aortic tree. With the creation of the LDL receptor knockout, and the different knockout and transgenic mice with changes in apoB, apoE, and the HDL system, a solid body of new information has emerged on the mechanisms regulating plasma lipoprotein levels and controlling the initial stages of atherogenesis. This paper presents an overview of the most utilized mouse models and a summary of the results obtained with the technique of bone marrow transplantation, an approach to study macrophages in atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11229870     DOI: 10.2741/fazio

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  31 in total

Review 1.  Regucalcin and metabolic disorders: osteoporosis and hyperlipidemia are induced in regucalcin transgenic rats.

Authors:  Masayoshi Yamaguchi
Journal:  Mol Cell Biochem       Date:  2010-03-28       Impact factor: 3.396

2.  Impaired cholesterol metabolism and enhanced atherosclerosis in clock mutant mice.

Authors:  Xiaoyue Pan; Xian-Cheng Jiang; M Mahmood Hussain
Journal:  Circulation       Date:  2013-09-06       Impact factor: 29.690

Review 3.  Immunological aspects of atherosclerosis.

Authors:  S Garrido-Urbani; M Meguenani; F Montecucco; B A Imhof
Journal:  Semin Immunopathol       Date:  2013-11-09       Impact factor: 9.623

4.  Atherosclerosis and vascular aging as modifiers of tumor progression, angiogenesis, and responsiveness to therapy.

Authors:  Halka Klement; Brad St Croix; Chloe Milsom; Linda May; Qing Guo; Joanne L Yu; Petr Klement; Janusz Rak
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

5.  A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates.

Authors:  Joyce C Y Chan; Derek E Piper; Qiong Cao; Dongming Liu; Chadwick King; Wei Wang; Jie Tang; Qiang Liu; Jared Higbee; Zhen Xia; Yongmei Di; Susan Shetterly; Ziva Arimura; Heather Salomonis; William G Romanow; Stephen T Thibault; Richard Zhang; Ping Cao; Xiao-Ping Yang; Timothy Yu; Mei Lu; Marc W Retter; Gayle Kwon; Kirk Henne; Oscar Pan; Mei-Mei Tsai; Bryna Fuchslocher; Evelyn Yang; Lei Zhou; Ki Jeong Lee; Mark Daris; Jackie Sheng; Yan Wang; Wenyan D Shen; Wen-Chen Yeh; Maurice Emery; Nigel P C Walker; Bei Shan; Margrit Schwarz; Simon M Jackson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-14       Impact factor: 11.205

6.  The atherogenic effect of excess methionine intake.

Authors:  Aron M Troen; Esther Lutgens; Donald E Smith; Irwin H Rosenberg; Jacob Selhub
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

7.  Sirt1 is involved in decreased bone formation in aged apolipoprotein E-deficient mice.

Authors:  Wei Hong; Xiao-ya Xu; Zhao-hui Qiu; Jian-jun Gao; Zhan-ying Wei; Li Zhen; Xiao-li Zhang; Zhi-bing Ye
Journal:  Acta Pharmacol Sin       Date:  2015-11-23       Impact factor: 6.150

8.  Programmable nanoparticle functionalization for in vivo targeting.

Authors:  Hua Pan; Jacob W Myerson; Lingzhi Hu; Jon N Marsh; Kirk Hou; Michael J Scott; John S Allen; Grace Hu; Susana San Roman; Gregory M Lanza; Robert D Schreiber; Paul H Schlesinger; Samuel A Wickline
Journal:  FASEB J       Date:  2012-10-09       Impact factor: 5.191

9.  Lipoprotein glomerulopathy induced by ApoE-Sendai is different from glomerular lesions in aged apoE-deficient mice.

Authors:  Atsunori Ishimura; Maho Watanabe; Hitoshi Nakashima; Kenji Ito; Katsuhisa Miyake; Shizue Mochizuki; Yasushi Ishigaki; Takao Saito
Journal:  Clin Exp Nephrol       Date:  2009-05-21       Impact factor: 2.801

10.  Humanized FcRn mouse models for evaluating pharmacokinetics of human IgG antibodies.

Authors:  Gabriele Proetzel; Derry C Roopenian
Journal:  Methods       Date:  2013-07-16       Impact factor: 3.608

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.